- Home
- SPRU vs CASI Comparison
SPRU vs CASI Comparison
Compare SPRU & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- CASI
- Stock Information
- Founded
- SPRU 2008
- CASI 1991
- Country
- SPRU United States
- CASI China
- Employees
- SPRU N/A
- CASI N/A
- Industry
- SPRU Auto Parts:O.E.M.
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- CASI Health Care
- Exchange
- SPRU Nasdaq
- CASI Nasdaq
- Market Cap
- SPRU 31.4M
- CASI 35.8M
- IPO Year
- SPRU N/A
- CASI 1996
- Fundamental
- Price
- SPRU $2.92
- CASI $2.03
- Analyst Decision
- SPRU
- CASI Strong Buy
- Analyst Count
- SPRU 0
- CASI 1
- Target Price
- SPRU N/A
- CASI $4.00
- AVG Volume (30 Days)
- SPRU 176.4K
- CASI 307.1K
- Earning Date
- SPRU 11-12-2025
- CASI 11-13-2025
- Dividend Yield
- SPRU N/A
- CASI N/A
- EPS Growth
- SPRU N/A
- CASI N/A
- EPS
- SPRU N/A
- CASI N/A
- Revenue
- SPRU $98,396,000.00
- CASI $31,564,000.00
- Revenue This Year
- SPRU $2.12
- CASI N/A
- Revenue Next Year
- SPRU N/A
- CASI N/A
- P/E Ratio
- SPRU N/A
- CASI N/A
- Revenue Growth
- SPRU 23.43
- CASI 36.64
- 52 Week Low
- SPRU $1.13
- CASI $1.09
- 52 Week High
- SPRU $3.38
- CASI $7.50
- Technical
- Relative Strength Index (RSI)
- SPRU 77.16
- CASI 54.22
- Support Level
- SPRU $2.35
- CASI $1.77
- Resistance Level
- SPRU $3.38
- CASI $2.08
- Average True Range (ATR)
- SPRU 0.24
- CASI 0.18
- MACD
- SPRU 0.11
- CASI 0.03
- Stochastic Oscillator
- SPRU 77.99
- CASI 81.61
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.